Dr. Choy’s presentation at the conference will highlight the importance of pre-clinical ADME for Phase 1 studies and provide the importance of Phase 1 ADME for further development. He will also offer details on dose adjustments in special populations, along with Drug-Drug interactions.
The Global Clinical Trial Operations conference brings together leaders, directors, vice presidents, heads, managers, supervisors, and CROs from all over the world to collaborate and discuss the latest developments in clinical trial operations and logistics and covers clinical trials in emerging markets, first-in-man clinical trials, pediatric clinical trials, material storage, distribution, site selection, patient recruitment and retention, technology in clinical trials and case studies of running global clinical trials.
For more information including a detailed agenda, exhibitor opportunities and registration information visit http://gtcbio.com/
